Cyclosporine A for Refractory Interstitial Cystitis/Bladder Pain Syndrome: Experience of 3 Tertiary Centers
The Journal of Urology, ISSN: 0022-5347, Vol: 188, Issue: 4, Page: 1186-1191
2012
- 66Citations
- 43Captures
- 1Mentions
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations66
- Citation Indexes64
- 64
- CrossRef46
- Policy Citations2
- 2
- Captures43
- Readers43
- 43
- Mentions1
- News Mentions1
- 1
Most Recent News
Bladder Pain Syndrome (BPS): A Comprehensive Review of Treatment Strategies and Management Approaches
Introduction Bladder pain syndrome (BPS) is a chronic and debilitating condition with unknown aetiology that can be difficult to treat due to its frequent links
Article Description
Cyclosporine A is a fifth-tier treatment option in the American Urological Association guidelines for interstitial cystitis/bladder pain syndrome. It was more effective than pentosanpolysulfate in a Finnish trial, but experience elsewhere is limited. Some centers use cyclosporine A off label for carefully selected patients but the number of patients in each center is small. We performed a retrospective review combining data from 3 tertiary centers that focus on interstitial cystitis/bladder pain syndrome.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S002253471203933X; http://dx.doi.org/10.1016/j.juro.2012.06.023; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84866064715&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/22901569; http://www.jurology.com/doi/10.1016/j.juro.2012.06.023; https://dx.doi.org/10.1016/j.juro.2012.06.023; https://www.auajournals.org/doi/10.1016/j.juro.2012.06.023
Ovid Technologies (Wolters Kluwer Health)
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know